67 related articles for article (PubMed ID: 1923589)
1. Microbial lung infections: new therapeutic strategies.
Döring G
Pathol Biol (Paris); 1991 Jun; 39(6):587-91. PubMed ID: 1923589
[No Abstract] [Full Text] [Related]
2. Pseudomonas in cystic fibrosis sylph or sycophant?
Fick RB
Clin Chest Med; 1981 Jan; 2(1):91-102. PubMed ID: 7030601
[No Abstract] [Full Text] [Related]
3. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
Hodson ME; Wingfield HJ; Batten JC
Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
[TBL] [Abstract][Full Text] [Related]
4. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications].
Rosselli P; Marianelli L; Valenza T; Bartolozzi G
Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104
[TBL] [Abstract][Full Text] [Related]
5. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
Hawley HB; Lewis RM; Swartz DR; Gump DW
Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
[No Abstract] [Full Text] [Related]
6. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
Kerrebijn KF; Mouton J
Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
[No Abstract] [Full Text] [Related]
7. Polymorphonuclear leukocyte elastase: its effects on the pathogenesis of Pseudomonas aeruginosa infection in cystic fibrosis.
Döring G
Antibiot Chemother (1971); 1989; 42():169-76. PubMed ID: 2688543
[No Abstract] [Full Text] [Related]
8. [Bronchial mucins and infection in cystic fibrosis].
Lamblin G; Ramphal R
Pathol Biol (Paris); 1991 Jun; 39(6):592-7. PubMed ID: 1923590
[No Abstract] [Full Text] [Related]
9. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
[No Abstract] [Full Text] [Related]
10. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
Michel BC
Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
[No Abstract] [Full Text] [Related]
11. Inhaled tobramycin (TOBI).
Bonsignore CL
Pediatr Nurs; 1998; 24(3):258-9. PubMed ID: 9987427
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
Høiby N; Giwercman B; Jensen ET; Pedersen SS; Koch C; Kharazmi A
Adv Pharmacol; 1994; 30():53-84. PubMed ID: 7833297
[No Abstract] [Full Text] [Related]
13. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
Bainbridge T; Fick RB
J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
[TBL] [Abstract][Full Text] [Related]
14. Update on treatment of pulmonary exacerbations in cystic fibrosis.
Smyth A
Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
16. Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis.
Prince AS; Neu HC
J Pediatr; 1980 Jul; 97(1):148-51. PubMed ID: 6445961
[No Abstract] [Full Text] [Related]
17. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
Hata JS; Fick RB
Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
[TBL] [Abstract][Full Text] [Related]
18. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
Madsen V; Lind A; Rasmussen M; Coulthard K
J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
[TBL] [Abstract][Full Text] [Related]
19. Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
Douchain F; Lebas L; Houdas S; Chivet C; Bakhache P; Pautard JC
Acta Univ Carol Med (Praha); 1990; 36(1-4):37-9. PubMed ID: 2130714
[No Abstract] [Full Text] [Related]
20. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
